These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 32934294)

  • 21. [Faecal microbiota study reveals specific dysbiosis in spondyloarthritis according to subtype, disease activity and treatment].
    Romero-Sánchez C; Ferrer-Santos C; Abril D; Acosta-Hernández E; Ávila J; Ramos-Casallas A; Escobar J; Bautista-Molano W; Jaimes D; Beltrán-Ostos A; Bello-Gualtero JM; Flórez-Sarmiento C; Parra-Izquierdo V; Calixto OJ
    Rev Alerg Mex; 2024 Feb; 71(1):81. PubMed ID: 38683098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
    Stecher B
    Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Increased Abundance of Clostridiaceae Characterizes Arthritis in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Cross-sectional Study.
    Muñiz Pedrogo DA; Chen J; Hillmann B; Jeraldo P; Al-Ghalith G; Taneja V; Davis JM; Knights D; Nelson H; Faubion WA; Raffals L; Kashyap PC
    Inflamm Bowel Dis; 2019 Apr; 25(5):902-913. PubMed ID: 30321331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects.
    Mielants H; Veys EM; Cuvelier C; De Vos M; Goemaere S; De Clercq L; Schatteman L; Elewaut D
    J Rheumatol; 1995 Dec; 22(12):2273-8. PubMed ID: 8835561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Human Gut Microbiota.
    Harmsen HJ; de Goffau MC
    Adv Exp Med Biol; 2016; 902():95-108. PubMed ID: 27161353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Gut Microbiome and Inflammatory Bowel Diseases.
    Shan Y; Lee M; Chang EB
    Annu Rev Med; 2022 Jan; 73():455-468. PubMed ID: 34555295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
    Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
    J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiome in primary sclerosing cholangitis: A review.
    Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
    World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal Inflammation as a Dysbiosis of Energy Procurement: New Insights into an Old Topic.
    Lee JS; Wang RX; Alexeev EE; Colgan SP
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 33583319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Microbiota and the Immune Response: What Is the Chicken and What Is the Egg?
    Fritsch J; Abreu MT
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):381-393. PubMed ID: 31078242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysbiosis in Inflammatory Bowel Disease: Pathogenic Role and Potential Therapeutic Targets.
    Santana PT; Rosas SLB; Ribeiro BE; Marinho Y; de Souza HSP
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.
    Salem F; Kindt N; Marchesi JR; Netter P; Lopez A; Kokten T; Danese S; Jouzeau JY; Peyrin-Biroulet L; Moulin D
    United European Gastroenterol J; 2019 Oct; 7(8):1008-1032. PubMed ID: 31662859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-B27 expression and reactive arthritis susceptibility in two patient cohorts infected with Salmonella Typhimurium.
    McColl GJ; Diviney MB; Holdsworth RF; McNair PD; Carnie J; Hart W; McCluskey J
    Aust N Z J Med; 2000 Feb; 30(1):28-32. PubMed ID: 10800874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host-microbiota interactions in inflammatory bowel disease.
    Neurath MF
    Nat Rev Gastroenterol Hepatol; 2020 Feb; 17(2):76-77. PubMed ID: 31848474
    [No Abstract]   [Full Text] [Related]  

  • 35. Metabolism at the centre of the host-microbe relationship.
    Maslowski KM
    Clin Exp Immunol; 2019 Aug; 197(2):193-204. PubMed ID: 31107965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease.
    Yadav A; Yadav R; Sharma V; Dutta U
    Indian J Gastroenterol; 2024 Feb; 43(1):112-128. PubMed ID: 38409485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
    Huh JW; Roh TY
    BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.
    Nanini HF; Bernardazzi C; Castro F; de Souza HSP
    World J Gastroenterol; 2018 Nov; 24(41):4622-4634. PubMed ID: 30416310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microbe-microbe and host-microbe interactions drive microbiome dysbiosis and inflammatory processes.
    Proal AD; Lindseth IA; Marshall TG
    Discov Med; 2017 Jan; 23(124):51-60. PubMed ID: 28245427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metagenomic analysis of bile salt biotransformation in the human gut microbiome.
    Das P; Marcišauskas S; Ji B; Nielsen J
    BMC Genomics; 2019 Jun; 20(1):517. PubMed ID: 31234773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.